Connection between inflammatory processes and transmittor function-Modulatory effects of interleukin-1

Progress in Neurobiology

Volumn 90, Issue 2, 2010, Pages 256-262

  Spulber, Stefan ^a   Schultzberg, Marianne ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Ageing; Alzheimer's disease; Cytokine; Development; IL 1 receptor antagonist; Inflammation; Neurodegeneration; Neurogenesis

Indexed keywords

AMYLOID PRECURSOR PROTEIN; CATECHOLAMINE; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; NEUROTRANSMITTER; TAU PROTEIN;

AGING; ALZHEIMER DISEASE; AMYLOIDOSIS; ANXIETY; BEHAVIOR DISORDER; BINDING AFFINITY; BRAIN DAMAGE; BRAIN ISCHEMIA; CELL ACTIVATION; CELL PROLIFERATION; CELL STRESS; CENTRAL NERVOUS SYSTEM DISEASE; CHRONIC INFLAMMATION; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DEGENERATIVE DISEASE; DISEASE COURSE; DISEASE EXACERBATION; EXCITOTOXICITY; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNOSTIMULATION; LEARNING; LONG TERM MEMORY; MICROGLIA; MONOCYTE; NERVE CELL LESION; NERVE CELL NECROSIS; NERVOUS SYSTEM INFLAMMATION; NEUROANATOMY; NEUROFIBRILLARY TANGLE; NEUROLOGIC DISEASE; NEUROMODULATION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FAMILY; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; SYSTEMIC DISEASE; TRAUMATIC BRAIN INJURY;

AGING; ANIMALS; BRAIN; DISEASE MODELS, ANIMAL; HUMANS; INFLAMMATION; INTERLEUKIN-1; LEARNING; MICE; MICE, TRANSGENIC; MICROGLIA; NEURODEGENERATIVE DISEASES;

EID: 76849105171     PISSN: 03010082     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pneurobio.2009.10.015     Document Type: Review

References (86)

1. Akaneya Y., Takahashi M., and Hatanaka H. Interleukin-1β enhances survival and interleukin-6 protects against MPP+ neurotoxicity in cultures of fetal rat dopaminergic neurons. Exp. Neurol. 136 (1995) 44-52
2. Allan S.M., Tyrrell P.J., and Rothwell N.J. Interleukin-1 and neuronal injury. Nat. Rev. Immunol. 5 (2005) 629-640
3. Andersson C., Svenson S.B., van Deventer S., Cerami A., and Bartfai T. Interleukin-1α expression is inducible by cholinergic stimulation in the rat adrenal gland. Neuroscience 47 (1992) 481-485
4. Arend W.P., Palmer G., and Gabay C. IL-1, IL-18, and IL-33 families of cytokines. Immunol. Rev. 223 (2008) 20-38
5. Atkins E., and Wood Jr. W.B. Studies on the pathogenesis of fever. I. The presence of transferable pyrogen in the blood stream following the injection of typhoid vaccine. J. Exp. Med. 101 (1955) 519-528
6. Bellinger F.P., Madamba S., and Siggins G.R. Interleukin 1β inhibits synaptic strength and long-term potentiation in the rat CA1 hippocampus. Brain Res. 628 (1993) 227-234
7. Bellucci A., Westwood A.J., Ingram E., Casamenti F., Goedert M., and Spillantini M.G. Induction of inflammatory mediators and microglial activation in mice transgenic for mutant human P301S tau protein. Am. J. Pathol. 165 (2004) 1643-1652
8. Besedovsky H.O., and Delrey A. Immune-neuro-endocrine interactions-facts and hypotheses. Endocr. Rev. 17 (1996) 64-102
9. Besedovsky H., Del Rey A., Sorkin E., and Dinarello C.A. Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones. Science 233 (1986) 652-654
10. Betz A.L., Yang G.-Y., and Davidson B.L. Attenuation of stroke size in rats using an adenoviral vector to induce overexpression of interleukin-1 receptor antagonist in brain. J. Cerebr. Blood Flow Metab. 15 (1995) 547-551
11. Brenneman D.E., Schultzberg M., Bartfai T., and Gozes I. Cytokine regulation of neuronal survival. J. Neurochem. 58 (1992) 454-460
12. Butterfield D.A., and Poon H.F. The senescence-accelerated prone mouse (SAMP8): a model of age-related cognitive decline with relevance to alterations of the gene expression and protein abnormalities in Alzheimer's disease. Exp. Gerontol. 40 (2005) 774-783
13. Buxbaum J.D., Oishi M., Chen H.I., Pinkas-Kramarski R., Jaffe E.A., Gandy S.E., and Greengard P. Cholinergic agonists and interleukin 1 regulate processing and secretion of the Alzheimer β/A4 amyloid protein precursor. Proc. Natl. Acad. Sci. U.S.A. 89 (1992) 10075-10078
14. Cacabelos R., Barquero M., Garcia P., Alvarez X.A., and Varela de Seijas E. Cerebrospinal fluid interleukin-1β (IL-1β) in Alzheimer's disease and neurological disorders. Methods Find. Exp. Clin. Pharmacol. 13 (1991) 455-458
15. Carvey P.M., Ling Z.D., Sortwell C.E., Pitzer M.R., McGuire S.O., Storch A., and Collier T.J. A clonal line of mesencephalic progenitor cells converted to dopamine neurons by hematopoietic cytokines: a source of cells for transplantation in Parkinson's disease. Exp. Neurol. 171 (2001) 98-108
16. Coogan A.N., O'Neill L.A., and O'Connor J.J. The P38 mitogen-activated protein kinase inhibitor SB203580 antagonizes the inhibitory effects of interleukin-1beta on long-term potentiation in the rat dentate gyrus in vitro. Neuroscience 93 (1999) 57-69
17. Coogan A.N., O'Neill L.A., and O'Connor J.J. The P38 mitogen-activated protein kinase inhibitor SB203580 antagonizes the inhibitory effects of interleukin-1β on long-term potentiation in the rat dentate gyrus in vitro. Neuroscience 93 (1999) 57-69
18. Dantzer R., and Kelley K.W. Twenty years of research on cytokine-induced sickness behavior. Brain Behav. Immun. 21 (2007) 153-160
19. Dantzer R., O'Connor J.C., Freund G.G., Johnson R.W., and Kelley K.W. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat. Rev. Neurosci. 9 (2008) 46-56
20. de la Mano A., Gato A., Alonso M.I., Carnicero E., Martin C., and Moro J.A. Role of interleukin-1β in the control of neuroepithelial proliferation and differentiation of the spinal cord during development. Cytokine 37 (2007) 128-137
21. Del Bo R., Angeretti N., Lucca E., De Simoni M.G., and Forloni G. Reciprocal control of inflammatory cytokines. IL-1 and IL-6, and beta-amyloid production in cultures. Neurosci. Lett. 188 (1995) 70-74
22. Deniz-Naranjo M.C., Munoz-Fernandez C., Alemany-Rodriguez M.J., Perez-Vieitez M.C., Aladro-Benito Y., Irurita-Latasa J., and Sanchez-Garcia F. Cytokine IL-1 beta but not IL-1 alpha promoter polymorphism is associated with Alzheimer disease in a population from the Canary Islands, Spain. Eur. J. Neurol. 15 (2008) 1080-1084
23. Dilger R.N., and Johnson R.W. Aging, microglial cell priming, and the discordant central inflammatory response to signals from the peripheral immune system. J. Leukoc. Biol. 84 (2008) 932-939
24. Dinarello C.A. Interleukin-1. Rev. Infect. Dis. 6 (1984) 51-95
25. Dinarello C.A. The interleukin-1 family: 10 years of discovery. FASEB J. 8 (1994) 1314-1325
26. Dinarello C.A. Immunological and inflammatory functions of the interleukin-1 family. Annu. Rev. Immunol. 27 (2009) 519-550
27. 3H-dihydroalprenolol binding sites and β-adrenergic receptors coupled within the central nervous system: pharmacological properties, distribution, and adaptive responsiveness. Mol. Pharmacol. 15 (1979) 1-15
28. Dong H., Csernansky C.A., Goico B., and Csernansky J.G. Hippocampal neurogenesis follows kainic acid-induced apoptosis in neonatal rats. J. Neurosci. 23 (2003) 1742-1749
29. Dunn A.J. Systemic interleukin-1 administration stimulates hypothalamic norepinephrine metabolism parallelling the increased plasma corticosterone. Life Sci. 43 (1988) 429-435
30. Dunn A.J. Effects of cytokines and infections on brain neurochemistry. Clin. Neurosci. Res. 6 (2006) 52-68
31. Dziegielewska K.M., Moller J.E., Potter A.M., Ek J., Lane M.A., and Saunders N.R. Acute-phase cytokines IL-1β and TNF-α in brain development. Cell Tissue Res. 299 (2000) 335-345
32. Engström L., Rosen K., Angel A., Fyrberg A., Mackerlova L., Konsman J.P., Engblom D., and Blomqvist A. Systemic immune challenge activates an intrinsically regulated local inflammatory circuit in the adrenal gland. Endocrinology 149 (2008) 1436-1450
33. Eriksson C., Winblad B., and Schultzberg M. Kainic acid induced expression of interleukin-1 receptor antagonist mRNA in the rat brain. Mol. Brain Res. 58 (1998) 195-208
34. Eriksson C., Van Dam A.M., Lucassen P.J., Bol J.G., Winblad B., and Schultzberg M. Immunohistochemical localization of interleukin-1β, interleukin-1 receptor antagonist and interleukin-1β converting enzyme/caspase-1 in the rat brain after peripheral administration of kainic acid. Neuroscience 93 (1999) 915-930
35. Eriksson C., Tehranian R., Iverfeldt K., Winblad B., and Schultzberg M. Increased expression of mRNA encoding interleukin-1β and caspase-1, and the secreted isoform of interleukin-1 receptor antagonist in the rat brain following systemic kainic acid administration. J. Neurosci. Res. 60 (2000) 266-279
36. Forloni G., Demicheli F., Giorgi S., Bendotti C., and Angeretti N. Expression of amyloid precursor protein mRNAs in endothelial, neuronal and glial cells: modulation by interleukin-1. Mol. Brain Res. 16 (1992) 128-134
37. Garcia J.H., Liu K.F., and Relton J.K. Interleukin-1 receptor antagonist decreases the number of necrotic neurons in rats with middle cerebral artery occlusion. Am. J. Pathol. 147 (1995) 1477-1486
38. Garlind A., Brauner A., Basun H., Höjeberg B., and Schultzberg M. Soluble interleukin-1 receptor type II levels are elevated in cerebrospinal fluid in Alzheimer's disease patients. Brain Res. 826 (1999) 112-116
39. Giulian D., Young D.G., Woodward J., Brown D.C., and Lachman L.B. Interleukin-1 is an astroglial growth factor in the developing brain. J. Neurosci. 8 (1988) 709-714
40. Godbout J.P., Chen J., Abraham J., Richwine A.F., Berg B.M., Kelley K.W., and Johnson R.W. Exaggerated neuroinflammation and sickness behavior in aged mice following activation of the peripheral innate immune system. FASEB J. 19 (2005) 1329-1331
41. Guzowski J.F., Setlow B., Wagner E.K., and McGaugh J.L. Experience-dependent gene expression in the rat hippocampus after spatial learning: a comparison of the immediate-early genes Arc, c-fos, and zif268. J. Neurosci. 21 (2001) 5089-5098
42. Hattiangady B., and Shetty A.K. Aging does not alter the number or phenotype of putative stem/progenitor cells in the neurogenic region of the hippocampus. Neurobiol. Aging 29 (2008) 129-147
43. Johansson S., and Strömberg I. Guidance of dopaminergic neuritic growth by immature astrocytes in organotypic cultures of rat fetal ventral mesencephalon. J. Comp. Neurol. 443 (2002) 237-249
44. Kabiersch A., del Rey A., Honegger C.G., and Besedovsky H.O. Interleukin-1 induces changes in norepinephrine metabolism in the rat brain. Brain Behav. Immun. 2 (1988) 267-274
45. Kinoshita D., Cohn D.W., Costa-Pinto F.A., and de Sa-Rocha L.C. Behavioral effects of LPS in adult, middle-aged and aged mice. Physiol. Behav. 96 (2009) 328-332
46. Kuhn H.G., Dickinson-Anson H., and Gage F.H. Neurogenesis in the dentate gyrus of the adult rat: age-related decrease of neuronal progenitor proliferation. J. Neurosci. 16 (1996) 2027-2033
47. Li Y., Liu L., Barger S.W., and Griffin W.S. Interleukin-1 mediates pathological effects of microglia on tau phosphorylation and on synaptophysin synthesis in cortical neurons through a p38-MAPK pathway. J. Neurosci. 23 (2003) 1605-1611
48. Lindberg C., Bardyl Selenica M.-L., Westlind-Danielsson A., and Schultzberg M. β-Amyloid protein structure determines the nature of cytokine release from rat microglia. J. Mol. Neurosci. 27 (2005) 1-12
49. Ling Z.D., Potter E.D., Lipton J.W., and Carvey P.M. Differentiation of mesencephalic progenitor cells into dopaminergic neurons by cytokines. Exp. Neurol. 149 (1998) 411-423
50. Lucas S.M., Rothwell N.J., and Gibson R.M. The role of inflammation in CNS injury and disease. Br. J. Pharmacol. 147 Suppl 1 (2006) S232-S240
51. Lundberg J.M., Hökfelt T., Hemsen A., Theodorsson-Norheim E., Pernow J., Hamberger B., and Goldstein M. Neuropeptide Y-like immunoreactivity in adrenaline cells of adrenal medulla and in tumors and plasma of pheochromocytoma patients. Regul. Pept. 13 (1986) 169-182
52. Lundkvist J., Sundgren-Andersson A.K., Tingsborg S., Östlund P., Engfors C., Alheim K., Bartfai T., Iverfeldt K., and Schultzberg M. Acute-phase responses in transgenic mice with CNS overexpression of IL-1 receptor antagonist. Am. J. Physiol. 276 (1999) R644-R651
53. McColl B.W., Rothwell N.J., and Allan S.M. Systemic inflammation alters the kinetics of cerebrovascular tight junction disruption after experimental stroke in mice. J. Neurosci. 28 (2008) 9451-9462
54. Mrak R.E., Sheng J.G., and Griffin W.S. Glial cytokines in Alzheimer's disease: review and pathogenic implications. Hum. Pathol. 26 (1995) 816-823
55. Nobel S., and Schultzberg M. Induction of interleukin-1β mRNA and enkephalin mRNA in the rat adrenal gland by lipopolysaccharides studied by in situ hybridization histochemistry. Neuroimmunomodulation 2 (1995) 61-73
56. O'Neill L.A. The interleukin-1 receptor/Toll-like receptor superfamily: 10 years of progress. Immunol. Rev. 226 (2008) 10-18
57. Oprica M., Zhu S., Goiny M., Pham T.M., Mohammed A., Winblad B., Bartfai T., and Schultzberg M. Transgenic overexpression of interleukin-1 receptor antagonist in the CNS influences behaviour, serum corticosterone and brain monoamines. Brain Behav. Immun. 19 (2005) 223-234
58. Oprica M., Hjorth E., Spulber S., Popescu B.O., Ankarcrona M., Winblad B., and Schultzberg M. Studies on brain volume, Alzheimer-related proteins and cytokines in mice with chronic overexpression of IL-1 receptor antagonist. J. Cell Mol. Med. 11 (2007) 810-825
59. Parish C.L., Finkelstein D.I., Tripanichkul W., Satoskar A.R., Drago J., and Horne M.K. The role of interleukin-1, interleukin-6, and glia in inducing growth of neuronal terminal arbors in mice. J. Neurosci. 22 (2002) 8034-8041
60. Priebe K., Romeo R.D., Francis D.D., Sisti H.M., Mueller A., McEwen B.S., and Brake W.G. Maternal influences on adult stress and anxiety-like behavior in C57BL/6J and BALB/cJ mice: a cross-fostering study. Dev. Psychobiol. 47 (2005) 398-407
61. Relton J.K., Martin D., Thompson R.C., and Russel D.A. Peripheral administration of interleukin-1 receptor antagonist inhibits brain damage after focal cerebral ischemia in the rat. Exp. Neurol. 138 (1996) 206-213
62. Riaz S.S., Theofilopoulos S., Jauniaux E., Stern G.M., and Bradford H.F. The differentiation potential of human foetal neuronal progenitor cells in vitro. Brain Res. Dev. Brain Res. 153 (2004) 39-51
63. Rooker S., Jander S., Van Reempts J., Stoll G., Jorens P.G., Borgers M., and Verlooy J. Spatiotemporal pattern of neuroinflammation after impact-acceleration closed head injury in the rat. Mediators Inflamm. 2006 (2006) 90123
64. Rosmaninho-Salgado J., Alvaro A.R., Grouzmann E., Duarte E.P., and Cavadas C. Neuropeptide Y regulates catecholamine release evoked by interleukin-1β in mouse chromaffin cells. Peptides 28 (2007) 310-314
65. Schneider H., Pitossi F., Balschun D., Wagner A., del Rey A., and Besedovsky H.O. A neuromodulatory role of interleukin-1β in the hippocampus. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 7778-7783
66. Schultzberg M., Lundberg J.M., Hökfelt T., Terenius L., Brandt J., Elde R.P., and Goldstein M. Enkephalin-like immunoreactivity in gland cells and nerve terminals of the adrenal medulla. Neuroscience 3 (1978) 1169-1186
67. Schultzberg M., Andersson C., Undén A., Troye-Blomberg M., Svenson S.B., and Bartfai T. Interleukin-1 in adrenal chromaffin cells. Neuroscience 30 (1989) 805-810
68. Schultzberg M., Tingsborg S., Nobel S., Lundkvist J., Svenson S., Simoncsits A., and Bartfai T. Interleukin-1 receptor antagonist protein and mRNA in the rat adrenal gland. J. Interferon Cytokine Res. 15 (1995) 723-731
69. Shaftel S.S., Griffin W.S., and O'Banion M.K. The role of interleukin-1 in neuroinflammation and Alzheimer disease: an evolving perspective. J. Neuroinflamm. 5 (2008) 7
70. Sheng J.G., Zhu S.G., Jones R.A., Griffin W.S., and Mrak R.E. Interleukin-1 promotes expression and phosphorylation of neurofilament and tau proteins in vivo. Exp. Neurol. 163 (2000) 388-391
71. Sparkman N.L., and Johnson R.W. Neuroinflammation associated with aging sensitizes the brain to the effects of infection or stress. Neuroimmunomodulation 15 (2008) 323-330
72. Spulber S., Oprica M., Bartfai T., Winblad B., and Schultzberg M. Blunted neurogenesis and gliosis due to transgenic overexpression of human soluble IL-1ra in the mouse. Eur. J. Neurosci. 27 (2008) 549-558
73. Spulber S., Mateos L., Oprica M., Cedazo-Minguez A., Bartfai T., Winblad B., and Schultzberg M. Impaired long term memory consolidation in transgenic mice overexpressing the human soluble form of IL-1ra in the brain. J. Neuroimmunol. 208 (2009) 46-53
74. Spulber, S., 2008. Blocking interleukin-1 signalling in the brain - structural and functional outcomes. Ph.D. thesis, Karolinska Institutet, Stockholm. ISBN 978-91-7409-167-0.
75. Storch A., Paul G., Csete M., Boehm B.O., Carvey P.M., Kupsch A., and Schwarz J. Long-term proliferation and dopaminergic differentiation of human mesencephalic neural precursor cells. Exp. Neurol. 170 (2001) 317-325
76. Stroemer R.P., and Rothwell N.J. Cortical protection by localized striatal injection of IL-1ra following cerebral ischemia in the rat. J. Cereb. Blood Flow Metab. 17 (1997) 597-604
77. Tanji K., Mori F., Imaizumi T., Yoshida H., Satoh K., and Wakabayashi K. Interleukin-1 induces tau phosphorylation and morphological changes in cultured human astrocytes. Neuroreport 14 (2003) 413-417
78. Tehranian R., Andell-Jonsson S., Beni S.M., Yatsiv I., Shohami E., Bartfai T., Lundkvist J., and Iverfeldt K. Improved recovery and delayed cytokine induction after closed head injury in mice with central overexpression of the secreted isoform of the interleukin-1 receptor antagonist. J. Neurotrauma 19 (2002) 939-951
79. Thornton P., Pinteaux E., Gibson R.M., Allan S.M., and Rothwell N.J. Interleukin-1-induced neurotoxicity is mediated by glia and requires caspase activation and free radical release. J. Neurochem. 98 (2006) 258-266
80. Trifunovic A., Wredenberg A., Falkenberg M., Spelbrink J.N., Rovio A.T., Bruder C.E., Bohlooly Y.M., Gidlof S., Oldfors A., Wibom R., Tornell J., Jacobs H.T., and Larsson N.G. Premature ageing in mice expressing defective mitochondrial DNA polymerase. Nature 429 (2004) 417-423
81. Vawter M.P., Basaric-Keys J., Li Y., Lester D.S., Lebovics R.S., Lesch K.P., Kulaga H., Freed W.J., Sunderland T., and Wolozin B. Human olfactory neuroepithelial cells: tyrosine phosphorylation and process extension are increased by the combination of IL-1β, IL-6, NGF, and bFGF. Exp. Neurol. 142 (1996) 179-194
82. Yang G.Y., Liu X.H., Kadoya C., Zhao Y.J., Mao Y., Davidson B.L., and Betz A.L. Attenuation of ischemic inflammatory response in mouse brain using an adenoviral vector to induce overexpression of interleukin-1 receptor antagonist. J. Cereb. Blood Flow Metab. 18 (1998) 840-847
83. Ye S.M., and Johnson R.W. Increased interleukin-6 expression by microglia from brain of aged mice. J. Neuroimmunol. 93 (1999) 139-148
84. Ye S.M., and Johnson R.W. An age-related decline in interleukin-10 may contribute to the increased expression of interleukin-6 in brain of aged mice. Neuroimmunomodulation 9 (2001) 183-192
85. Yirmiya R., Winocur G., and Goshen I. Brain interleukin-1 is involved in spatial memory and passive avoidance conditioning. Neurobiol. Learn Mem. 78 (2002) 379-389
86. Zaharia M.D., Kulczycki J., Shanks N., Meaney M.J., and Anisman H. The effects of early postnatal stimulation on Morris water-maze acquisition in adult mice: genetic and maternal factors. Psychopharmacology (Berl) 128 (1996) 227-239